Tara M. Raghavan

Arnold B. Calmann

Matthew V. Anderson

Katherine Ann Escanlar

Jeffrey S. Soos

Deanne M. Mazzochi

Paul J. Molino

William A. Rakoczy

Katie Boda

Rachel A. Smoot

Christopher N. Sipes

Jeremy D. Cobb

Eric R. Sonnenschein

R. Jason Fowler

Bradley K. Ervin

William C. Baton

Charles M. Lizza

Sarah Ann Sullivan

David L. Moses

ANDA filing triggers Boehringer challenge to Lupin's generic Spiriva over patents on its `double function actuating member` inhaler for COPD treatment.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
Boehringer-Ingelheim Pharma GmbH	L3 A
Boehringer-Ingelheim Pharmaceuticals Inc	L3 A
Boehringer Ingelheim Intl GmbH	L3 A

Name	Ratings
Saul Ewing LLP	L4 B
William C. Baton	L5 A
Charles M. Lizza	L5 A
David L. Moses	L5 A
Sarah Ann Sullivan	L5 A
Covington & Burling LLP	L4 B
Christopher N. Sipes	L4 D
Eric R. Sonnenschein	L3 A
R. Jason Fowler	L3 E
Jeremy D. Cobb	L2 E
Bradley K. Ervin	L1 C

Name	Ratings
Lupin Ltd	L4 E
Lupin Atlantis Holdings SA	L4 E

Name	Ratings
SaiberLocal	L3 D
Arnold B. Calmann	L5 E
Katherine Ann Escanlar	L5 E
Jeffrey S. Soos	L5 E
Rakoczy Molino Mazzochi Siwik LLP	L3 E
Deanne M. Mazzochi	L5 E
William A. Rakoczy	L5 E
Matthew V. Anderson	L3 D
Tara M. Raghavan	L3 E
Paul J. Molino	L3 E
Katie Boda	-- -- --
Rachel A. Smoot	-- -- --

2:18-cv-12663

Boehringer Ingelheim Pharma GmbH Co KG v. Lupin Ltd